🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆
Updated 13 Sep 2026 · ClinicalTrials.gov

Clinical Trials in Colorado

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

32
Recruiting now
50
Studies tracked
Colorado
Selected state
Recruiting Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC · started 2024-06-24
Alabama · Arizona · California · Colorado · Connecticut · Delaware · Florida · Georgia
NCT06393374 on ClinicalTrials.gov ↗
Recruiting Phase 3
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Urothelial Cancer, Urinary Bladder Neoplasms
Astellas Pharma Global Development, Inc. · started 2026-05-11
California · Colorado · Delaware · Illinois · Indiana · Missouri · Ohio · Oregon
NCT07566156 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
BeOne Medicines · started 2021-09-13
Alabama · Arizona · California · Colorado · Florida · Georgia · Illinois · Iowa
NCT05006716 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
Parkinson's Disease
Hoffmann-La Roche · started 2017-06-27
Alabama · Arizona · California · Colorado · Connecticut · Florida · Illinois · Kansas
NCT03100149 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC · started 2025-06-30
Arizona · California · Colorado · Florida · Georgia · Indiana · Louisiana · Maine
NCT06966700 on ClinicalTrials.gov ↗
Recruiting Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Attention-Deficit/Hyperactivity Disorder
Supernus Pharmaceuticals, Inc. · started 2024-03-19
Alabama · Arkansas · California · Colorado · Florida · Georgia · Indiana · Kentucky
NCT04781140 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
BeOne Medicines · started 2026-01-22
California · Colorado · Florida · Illinois · Louisiana · Massachusetts · Minnesota · Nebraska
NCT07277231 on ClinicalTrials.gov ↗
Recruiting Phase 3
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Glioblastoma, Recurrent Glioblastoma, GBM
CarThera · started 2024-01-29
Arizona · California · Colorado · Florida · Georgia · Illinois · Indiana · Maryland
NCT05902169 on ClinicalTrials.gov ↗
By invitation Phase 3
An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Biogen · started 2022-06-10
Arizona · California · Colorado · District of Columbia · Florida · Georgia · Massachusetts · Michigan
NCT05352919 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML), FLT3-mutated Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. · started 2023-01-31
California · Colorado · Florida · Illinois · Maryland · New York · North Carolina · Ohio
NCT05520567 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
Merck Sharp & Dohme LLC · started 2024-08-16
California · Colorado · Connecticut · Florida · Iowa · Massachusetts · Michigan · Missouri
NCT06395103 on ClinicalTrials.gov ↗
Starting soon Phase 3
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Migraine
Kallyope Inc. · started 2026-09
Arizona · Arkansas · California · Colorado · Connecticut · Florida · Georgia · Idaho
NCT07816367 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Asthma
Teva Branded Pharmaceutical Products R&D LLC · started 2023-08-30
Alabama · Arizona · California · Colorado · District of Columbia · Florida · Georgia · Idaho
NCT06052267 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
Merck Sharp & Dohme LLC · started 2026-05-03
Colorado · Tennessee
NCT07519772 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Small Cell Lung Cancer Extensive Stage
Genprex, Inc. · started 2024-05-09
Colorado · Missouri · Ohio · Oregon · Texas · Virginia · Washington
NCT05703971 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Metastatic Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma
Adcendo ApS · started 2025-06-05
Colorado · Florida · New York · Texas
NCT06797999 on ClinicalTrials.gov ↗
By invitation Phase 3
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Viatris Innovation GmbH · started 2024-07-30
Colorado · Florida · Louisiana · Nevada · Texas
NCT06475742 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
AbbVie · started 2023-12-11
Arizona · Arkansas · California · Colorado · Florida · Indiana · Massachusetts · Minnesota
NCT05995353 on ClinicalTrials.gov ↗
Recruiting Phase 2
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Crohn's Disease, Ulcerative Colitis
AbbVie · started 2026-07-31
Alabama · Arizona · California · Colorado · Florida · Georgia · Idaho · Illinois
NCT07697456 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Malignant Neoplasm
Merck Sharp & Dohme LLC · started 2026-07-06
Colorado · Iowa · Massachusetts · Michigan · New Jersey · New York · North Dakota · Pennsylvania
NCT07630974 on ClinicalTrials.gov ↗
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Pain
Boston Scientific Corporation · started 2012-11-19
Arizona · California · Colorado · Florida · Georgia · Illinois · Indiana · Kansas
NCT01719055 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
AstraZeneca · started 2024-04-12
Alabama · Arizona · Arkansas · California · Colorado · Florida · Georgia · Illinois
NCT06307652 on ClinicalTrials.gov ↗
Recruiting Phase 1
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer
BeOne Medicines · started 2023-12-01
Colorado · Florida · Michigan · Missouri · North Carolina · Ohio · Tennessee · Texas
NCT06120283 on ClinicalTrials.gov ↗
Active Phase 1
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Tizona Therapeutics, Inc · started 2020-07-14
Arizona · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Illinois
NCT04485013 on ClinicalTrials.gov ↗
Active Phase 3
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
Hypertension
Mineralys Therapeutics Inc. · started 2023-07-14
Alabama · Arizona · California · Colorado · Connecticut · Florida · Georgia · Idaho
NCT05968430 on ClinicalTrials.gov ↗
Active
CHAMPION-AF Clinical Trial
Atrial Fibrillation, Stroke, Bleeding
Boston Scientific Corporation · started 2020-10-15
Alabama · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia
NCT04394546 on ClinicalTrials.gov ↗
Active Phase 3
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
Stage IB-IIIA Non-small Cell Lung Carcinoma
AstraZeneca · started 2015-10-21
California · Colorado · Connecticut · Florida · Georgia · Hawaii · Illinois · Maryland
NCT02511106 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
CKD, Metabolic Acidosis
Renibus Therapeutics, Inc. · started 2026-01-13
California · Colorado · Delaware · Florida · Georgia · Idaho · Illinois · Indiana
NCT07355062 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Non Small Cell Lung Carcinoma
AbbVie · started 2025-03-06
Arizona · California · Colorado · Florida · Illinois · Indiana · Kansas · Massachusetts
NCT06772623 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
Diffuse Large B-Cell Lymphoma
Genmab · started 2023-02-08
Arizona · Arkansas · California · Colorado · Florida · Hawaii · Illinois · Indiana
NCT05578976 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Hemophilia B
Regeneron Pharmaceuticals · started 2024-09-11
California · Colorado · Connecticut · Florida · Indiana · Louisiana · Michigan · Ohio
NCT06379789 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
Biogen · started 2022-09-13
Alabama · Arizona · California · Colorado · Florida · Georgia · Illinois · Indiana
NCT05531565 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
Narcolepsy Type 1, Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited · started 2026-05-29
Alabama · Colorado · Florida · Georgia · Mississippi · North Carolina · Ohio · South Carolina
NCT07598708 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Alzheimer's Disease
AbbVie · started 2026-05-15
California · Colorado · Florida · Massachusetts · Tennessee · Texas
NCT07599670 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Metastatic Colorectal Cancer
Hoffmann-La Roche · started 2021-10-22
Alabama · Arizona · California · Colorado · Connecticut · Florida · Illinois · Louisiana
NCT04929223 on ClinicalTrials.gov ↗
Active Phase 2
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
Prostatic Neoplasm
Novartis Pharmaceuticals · started 2024-01-03
Colorado · Georgia · Indiana · Iowa · Nebraska · Oregon · Pennsylvania · Texas
NCT05849298 on ClinicalTrials.gov ↗
Active
The PEERLESS II Study
Pulmonary Embolism
Inari Medical · started 2023-11-17
Alabama · California · Colorado · Connecticut · Florida · Georgia · Illinois · Michigan
NCT06055920 on ClinicalTrials.gov ↗
Active Phase 2
Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Gilead Sciences · started 2022-05-30
Alaska · California · Colorado · District of Columbia · Florida · Georgia · Illinois · Kansas
NCT05186974 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals · started 2025-05-30
Arizona · Arkansas · Colorado · Connecticut · Florida · Georgia · Kentucky · Louisiana
NCT06784752 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer · started 2026-01-30
Arkansas · California · Colorado · Florida · New Jersey · New York · Oregon · Texas
NCT07227298 on ClinicalTrials.gov ↗
Recruiting Phase 2
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Hoffmann-La Roche · started 2025-03-05
Alaska · California · Colorado · Florida · Idaho · Illinois · Iowa · Kentucky
NCT06806033 on ClinicalTrials.gov ↗
Active Phase 3
177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
Prostatic Neoplasms
Novartis Pharmaceuticals · started 2021-06-15
Colorado · Florida · Louisiana · Massachusetts · Missouri · Nebraska · New York · North Carolina
NCT04689828 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Amgen · started 2025-11-28
Arizona · California · Colorado · Connecticut · Delaware · Florida · Georgia · Illinois
NCT07213674 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prostate Cancer, Prostatic Neoplasms
Merck Sharp & Dohme LLC · started 2025-05-13
Arizona · California · Colorado · Connecticut · District of Columbia · Florida · Georgia · Illinois
NCT06925737 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Type 1 Diabetes Mellitus, T1D, T1DM, T1DM - Type 1 Diabetes Mellitus
COUR Pharmaceutical Development Company, Inc. · started 2025-05-12
Arizona · California · Colorado · Florida · Georgia · Idaho · Illinois · Indiana
NCT06783309 on ClinicalTrials.gov ↗
Starting soon Phase 3
iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma
Melanoma (Skin Cancer), Advanced Melanoma, Metastatic Melanoma, Skin Cancer
Scancell Ltd · started 2026-12-01
Colorado
NCT07815574 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Diffuse Large B-Cell Lymphoma
Merck Sharp & Dohme LLC · started 2025-01-27
Alabama · Arizona · California · Colorado · Florida · Georgia · Illinois · Indiana
NCT06717347 on ClinicalTrials.gov ↗
Active
SIMPLAAFY Clinical Trial
Atrial Fibrillation, Stroke, Bleeding
Boston Scientific Corporation · started 2024-10-01
Alabama · Arizona · Arkansas · California · Colorado · Connecticut · District of Columbia · Florida
NCT06521463 on ClinicalTrials.gov ↗
Recruiting Phase 3
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Immuneering Corporation · started 2026-06-05
Alabama · Arizona · California · Colorado · Delaware · Florida · Georgia · Illinois
NCT07562152 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
AstraZeneca · started 2025-03-01
Alaska · Arizona · California · Colorado · Delaware · Florida · Georgia · Illinois
NCT06764875 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 102 Florida · 94 Illinois · 59 Georgia · 53 Arizona · 50 Colorado · 50 Texas · 40 New York · 37 Alabama · 33 Connecticut · 32 Massachusetts · 31 Michigan · 28 Ohio · 28 Indiana · 25 North Carolina · 23 Maryland · 21

Browse by condition

Breast Cancer · 5 Advanced Solid Tumor · 4 Obesity · 4 Chronic Lymphocytic Leukemia · 3 Ovarian Cancer · 3 Non-small Cell Lung Cancer · 3 Ulcerative Colitis · 3 Crohn's Disease · 3 Diffuse Large B-Cell Lymphoma · 3 Small Lymphocytic Lymphoma · 2 Urinary Bladder Neoplasms · 2 Marginal Zone Lymphoma · 2 Multiple Myeloma · 2 Pulmonary Embolism · 2 Bladder Cancer · 2 Small Cell Lung Cancer · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/colorado (Accessed: 13 September 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.